Scibase Q4’23: Impressive gross margin while sales came in softer - Redeye
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

Scibase Q4’23: Impressive gross margin while sales came in softer - Redeye

{newsItem.title}

Redeye saw a Q4 report showing sales below our estimates, with a total growth of 16% for the quarter. Costs were higher than expected again, mainly driven by the marketing efforts that continue in the US. The gross margin was higher than expected at 73.5%. Adjusted for fx effects, it was still higher than expected at 72% vs. our estimate of 66%. The EBIT result was SEK -15.7m vs. our estimate of -11.7m; the higher marketing costs and R&D mostly drove the deviation. Growth continues excellently in Germany, while US sales have also shown good growth, although at low absolute levels.

Länk till analysen i sin helhet: https://www.redeye.se/research/983316/scibase-q423-impressive-gross-margin-while-sales-came-in-softer?utm_source=finwire&utm_medium=RSS

Nyheter om Scibase

Läses av andra just nu

Om aktien Scibase

Senaste nytt